Entry - #610246 - SPINOCEREBELLAR ATAXIA 28; SCA28 - OMIM
# 610246

SPINOCEREBELLAR ATAXIA 28; SCA28


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
18p11.21 Spinocerebellar ataxia 28 610246 AD 3 AFG3L2 604581
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal dominant
HEAD & NECK
Eyes
- Eye movement abnormalities
- Dysmetric saccades
- Smooth pursuit abnormalities
- Gaze-evoked nystagmus
- Slow saccades (with longer disease duration)
- Ophthalmoparesis (with longer disease duration)
- Ptosis (with longer disease duration)
NEUROLOGIC
Central Nervous System
- Gait ataxia
- Limb ataxia
- Dysarthria
- Hyperreflexia in the lower limbs
- Increased muscle tone in the lower limbs
- Extensor plantar responses
- Dystonia (less common)
- Parkinsonism (less common)
- Spasticity
- Cerebellar atrophy
MISCELLANEOUS
- Mean age at onset 30.7 years (range 6 to 60 years)
- Slow progression
MOLECULAR BASIS
- Caused by mutation in the AFG3-like matrix AAA peptidase, subunit 2 gene (AFG3L2, 604581.0001)
Spinocerebellar ataxia - PS164400 - 49 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
1p36.33 Spinocerebellar ataxia 21 AD 3 607454 TMEM240 616101
1p35.2 Spinocerebellar ataxia 47 AD 3 617931 PUM1 607204
1p32.2-p32.1 Spinocerebellar ataxia 37 AD 3 615945 DAB1 603448
1p13.2 Spinocerebellar ataxia 19 AD 3 607346 KCND3 605411
2p16.1 Spinocerebellar ataxia 25 AD 3 608703 PNPT1 610316
3p26.1 Spinocerebellar ataxia 15 AD 3 606658 ITPR1 147265
3p26.1 Spinocerebellar ataxia 29, congenital nonprogressive AD 3 117360 ITPR1 147265
3p14.1 Spinocerebellar ataxia 7 AD 3 164500 ATXN7 607640
3q25.2 ?Spinocerebellar ataxia 43 AD 3 617018 MME 120520
4q27 ?Spinocerebellar ataxia 41 AD 3 616410 TRPC3 602345
4q34.3-q35.1 ?Spinocerebellar ataxia 30 AD 2 613371 SCA30 613371
5q32 Spinocerebellar ataxia 12 AD 3 604326 PPP2R2B 604325
5q33.1 Spinocerebellar ataxia 45 AD 3 617769 FAT2 604269
6p22.3 Spinocerebellar ataxia 1 AD 3 164400 ATXN1 601556
6p12.1 Spinocerebellar ataxia 38 AD 3 615957 ELOVL5 611805
6q14.1 Spinocerebellar ataxia 34 AD 3 133190 ELOVL4 605512
6q24.3 Spinocerebellar ataxia 44 AD 3 617691 GRM1 604473
6q27 Spinocerebellar ataxia 17 AD 3 607136 TBP 600075
7q21.2 ?Spinocerebellar ataxia 49 AD 3 619806 SAMD9L 611170
7q22-q32 Spinocerebellar ataxia 18 AD 2 607458 SCA18 607458
7q32-q33 Spinocerebellar ataxia 32 AD 2 613909 SCA32 613909
11q12 Spinocerebellar ataxia 20 AD 4 608687 SCA20 608687
11q13.2 Spinocerebellar ataxia 5 AD 3 600224 SPTBN2 604985
12q24.12 Spinocerebellar ataxia 2 AD 3 183090 ATXN2 601517
12q24.12 {Amyotrophic lateral sclerosis, susceptibility to, 13} AD 3 183090 ATXN2 601517
13q21 Spinocerebellar ataxia 8 AD 3 608768 ATXN8 613289
13q21.33 Spinocerebellar ataxia 8 AD 3 608768 ATXN8OS 603680
13q33.1 Spinocerebellar ataxia 27A AD 3 193003 FGF14 601515
13q33.1 Spinocerebellar ataxia 27B, late-onset AD 3 620174 FGF14 601515
14q32.11-q32.12 ?Spinocerebellar ataxia 40 AD 3 616053 CCDC88C 611204
14q32.12 Machado-Joseph disease AD 3 109150 ATXN3 607047
15q15.2 Spinocerebellar ataxia 11 AD 3 604432 TTBK2 611695
16p13.3 Spinocerebellar ataxia 48 AD 3 618093 STUB1 607207
16q21 Spinocerebellar ataxia 31 AD 3 117210 BEAN1 612051
16q22.1 Spinocerebellar ataxia 51 AD 3 620947 THAP11 609119
16q22.2-q22.3 Spinocerebellar ataxia 4 AD 3 600223 ZFHX3 104155
17q21.33 Spinocerebellar ataxia 42 AD 3 616795 CACNA1G 604065
17q25.3 Spinocerebellar ataxia 50 AD 3 620158 NPTX1 602367
18p11.21 Spinocerebellar ataxia 28 AD 3 610246 AFG3L2 604581
19p13.3 ?Spinocerebellar ataxia 26 AD 3 609306 EEF2 130610
19p13.13 Spinocerebellar ataxia 6 AD 3 183086 CACNA1A 601011
19q13.2 ?Spinocerebellar ataxia 46 AD 3 617770 PLD3 615698
19q13.33 Spinocerebellar ataxia 13 AD 3 605259 KCNC3 176264
19q13.42 Spinocerebellar ataxia 14 AD 3 605361 PRKCG 176980
20p13 Spinocerebellar ataxia 23 AD 3 610245 PDYN 131340
20p13 Spinocerebellar ataxia 35 AD 3 613908 TGM6 613900
20p13 Spinocerebellar ataxia 36 AD 3 614153 NOP56 614154
22q13.31 Spinocerebellar ataxia 10 AD 3 603516 ATXN10 611150
Not Mapped Spinocerebellar ataxia 9 612876 SCA9 612876

TEXT

A number sign (#) is used with this entry because of evidence that spinocerebellar ataxia-28 (SCA28) is caused by heterozygous mutation in the AFG3L2 gene (604581) on chromosome 18p11.

Heterozygous mutation in the AFG3L2 gene can also cause optic atrophy-12 (OPA12; 618977), and biallelic mutation in the AFG3L2 gene can cause autosomal recessive spastic ataxia-5 (SPAX5; 614487).

For a general discussion of autosomal dominant spinocerebellar ataxia, see SCA1 (164400).


Clinical Features

Cagnoli et al. (2006) reported a 4-generation Italian family in which at least 14 members were affected with juvenile-onset spinocerebellar ataxia inherited in an autosomal dominant pattern. The mean age at onset was 19.5 years (range 12 to 36) with unbalanced standing and gait abnormalities. Other features included limb ataxia, dysarthria, slow and lower limb hyperreflexia. Two patterns of eye movement abnormalities were observed: patients with shorter disease duration had gaze-evoked nystagmus, while those with longer disease duration showed dysmetric saccades, slow saccades, ophthalmoparesis, and ptosis. The disorder was slowly progressive, and there was no evidence of sensory involvement or cognitive impairment. Brain MRI showed cerebellar atrophy.

Cagnoli et al. (2010) reported 9 European families, including 8 of French and 1 of Italian origin, with autosomal dominant SCA28 confirmed by genetic analysis. The mean age at onset was 30.7 years (range, 6 to 60 years), and most patients presented with cerebellar ataxia. Other features included dysarthria (68%), ophthalmoplegia (48%) and/or gazed-evoked nystagmus (54%), saccadic pursuit (37%), slow saccades (25%), and ptosis (42%). Six patients had a full pyramidal syndrome, with increased reflexes and Babinski sign, whereas 1 had gait spasticity. Rare individuals had dystonia or parkinsonism. Overall, the disease was slowly progressive and did not result in major functional incapacity.


Inheritance

The transmission pattern of SCA28 in the families reported by Di Bella et al. (2010) was consistent with autosomal dominant inheritance.


Mapping

By genomewide linkage analysis of a large Italian family, Cagnoli et al. (2006) identified a candidate disease locus, termed SCA28, on chromosome 18p11.22-q11.2 (maximum 2-point lod score of 4.20 for marker D18S53; maximum multipoint lod score of 4.77 at D18S453). Haplotype analysis defined a 7.9-Mb region between D18S1418 and D18S1104.


Molecular Genetics

In affected members of 5 unrelated families with SCA28, including the family reported by Cagnoli et al. (2006), Di Bella et al. (2010) identified 5 different heterozygous mutations in the AFG3L2 gene (604581.0001-604581.0005). Studies in yeast showed that the mutations affected mitochondrial respiratory and proteolytic functions of the protein by both dominant-negative (E691K; 604581.0001) and loss of function (see, e.g., S674L; 604581.0002) mechanisms. Di Bella et al. (2010) hypothesized that AFG3L2 or specific substrates of AFG3L2 may have an essential function in protecting the cerebellum from neurodegeneration.

Cagnoli et al. (2010) identified 6 different missense mutations in exons 15 and 16 of the AFG3L2 gene (see, e.g., 604581.0006-604581.0009) in 9 (2.6%) of 366 Caucasian European probands with autosomal dominant SCA who were negative for the most common triplet expansions in other genes. Pathogenic copy number variations of the AFG3L2 gene were not detected.


REFERENCES

  1. Cagnoli, C., Mariotti, C., Taroni, F., Seri, M., Brussino, A., Michielotto, C., Grisoli, M., Di Bella, D., Migone, N., Gellera, C., Di Donato, S., Brusco, A. SCA28, a novel form of autosomal dominant cerebellar ataxia on chromosome 18p11.22-q11.2. Brain 129: 235-242, 2006. [PubMed: 16251216, related citations] [Full Text]

  2. Cagnoli, C., Stevanin, G., Brussino, A., Barberis, M., Mancini, C., Margolis, R. L., Holmes, S. E., Nobili, M., Forlani, S., Padovan, S., Pappi, P., Zaros, C., Leber, I., Ribai, P., Pugliese, L., Assalto, C., Brice, A., Migone, N., Durr, A., Brusco, A. Missense mutations in the AFG3L2 proteolytic domain account for ~1.5% of European autosomal dominant cerebellar ataxias. Hum. Mutat. 31: 1117-1124, 2010. [PubMed: 20725928, related citations] [Full Text]

  3. Di Bella, D., Lazzaro, F., Brusco, A., Plumari, M., Battaglia, G., Pastore, A., Finardi, A., Cagnoli, C., Tempia, F., Frontali, M., Veneziano, L., Sacco, T., and 14 others. Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28. Nature Genet. 42: 313-321, 2010. [PubMed: 20208537, related citations] [Full Text]


Cassandra L. Kniffin - updated : 2/24/2011
Cassandra L. Kniffin - updated : 5/6/2010
Creation Date:
Cassandra L. Kniffin : 7/11/2006
alopez : 03/22/2024
carol : 08/14/2020
ckniffin : 08/10/2020
carol : 05/25/2016
carol : 1/20/2015
carol : 8/9/2013
wwang : 3/18/2011
ckniffin : 2/24/2011
terry : 12/22/2010
wwang : 5/18/2010
ckniffin : 5/6/2010
wwang : 7/14/2006
ckniffin : 7/11/2006

# 610246

SPINOCEREBELLAR ATAXIA 28; SCA28


SNOMEDCT: 715824008;   ORPHA: 101109;   DO: 0050977;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
18p11.21 Spinocerebellar ataxia 28 610246 Autosomal dominant 3 AFG3L2 604581

TEXT

A number sign (#) is used with this entry because of evidence that spinocerebellar ataxia-28 (SCA28) is caused by heterozygous mutation in the AFG3L2 gene (604581) on chromosome 18p11.

Heterozygous mutation in the AFG3L2 gene can also cause optic atrophy-12 (OPA12; 618977), and biallelic mutation in the AFG3L2 gene can cause autosomal recessive spastic ataxia-5 (SPAX5; 614487).

For a general discussion of autosomal dominant spinocerebellar ataxia, see SCA1 (164400).


Clinical Features

Cagnoli et al. (2006) reported a 4-generation Italian family in which at least 14 members were affected with juvenile-onset spinocerebellar ataxia inherited in an autosomal dominant pattern. The mean age at onset was 19.5 years (range 12 to 36) with unbalanced standing and gait abnormalities. Other features included limb ataxia, dysarthria, slow and lower limb hyperreflexia. Two patterns of eye movement abnormalities were observed: patients with shorter disease duration had gaze-evoked nystagmus, while those with longer disease duration showed dysmetric saccades, slow saccades, ophthalmoparesis, and ptosis. The disorder was slowly progressive, and there was no evidence of sensory involvement or cognitive impairment. Brain MRI showed cerebellar atrophy.

Cagnoli et al. (2010) reported 9 European families, including 8 of French and 1 of Italian origin, with autosomal dominant SCA28 confirmed by genetic analysis. The mean age at onset was 30.7 years (range, 6 to 60 years), and most patients presented with cerebellar ataxia. Other features included dysarthria (68%), ophthalmoplegia (48%) and/or gazed-evoked nystagmus (54%), saccadic pursuit (37%), slow saccades (25%), and ptosis (42%). Six patients had a full pyramidal syndrome, with increased reflexes and Babinski sign, whereas 1 had gait spasticity. Rare individuals had dystonia or parkinsonism. Overall, the disease was slowly progressive and did not result in major functional incapacity.


Inheritance

The transmission pattern of SCA28 in the families reported by Di Bella et al. (2010) was consistent with autosomal dominant inheritance.


Mapping

By genomewide linkage analysis of a large Italian family, Cagnoli et al. (2006) identified a candidate disease locus, termed SCA28, on chromosome 18p11.22-q11.2 (maximum 2-point lod score of 4.20 for marker D18S53; maximum multipoint lod score of 4.77 at D18S453). Haplotype analysis defined a 7.9-Mb region between D18S1418 and D18S1104.


Molecular Genetics

In affected members of 5 unrelated families with SCA28, including the family reported by Cagnoli et al. (2006), Di Bella et al. (2010) identified 5 different heterozygous mutations in the AFG3L2 gene (604581.0001-604581.0005). Studies in yeast showed that the mutations affected mitochondrial respiratory and proteolytic functions of the protein by both dominant-negative (E691K; 604581.0001) and loss of function (see, e.g., S674L; 604581.0002) mechanisms. Di Bella et al. (2010) hypothesized that AFG3L2 or specific substrates of AFG3L2 may have an essential function in protecting the cerebellum from neurodegeneration.

Cagnoli et al. (2010) identified 6 different missense mutations in exons 15 and 16 of the AFG3L2 gene (see, e.g., 604581.0006-604581.0009) in 9 (2.6%) of 366 Caucasian European probands with autosomal dominant SCA who were negative for the most common triplet expansions in other genes. Pathogenic copy number variations of the AFG3L2 gene were not detected.


REFERENCES

  1. Cagnoli, C., Mariotti, C., Taroni, F., Seri, M., Brussino, A., Michielotto, C., Grisoli, M., Di Bella, D., Migone, N., Gellera, C., Di Donato, S., Brusco, A. SCA28, a novel form of autosomal dominant cerebellar ataxia on chromosome 18p11.22-q11.2. Brain 129: 235-242, 2006. [PubMed: 16251216] [Full Text: https://doi.org/10.1093/brain/awh651]

  2. Cagnoli, C., Stevanin, G., Brussino, A., Barberis, M., Mancini, C., Margolis, R. L., Holmes, S. E., Nobili, M., Forlani, S., Padovan, S., Pappi, P., Zaros, C., Leber, I., Ribai, P., Pugliese, L., Assalto, C., Brice, A., Migone, N., Durr, A., Brusco, A. Missense mutations in the AFG3L2 proteolytic domain account for ~1.5% of European autosomal dominant cerebellar ataxias. Hum. Mutat. 31: 1117-1124, 2010. [PubMed: 20725928] [Full Text: https://doi.org/10.1002/humu.21342]

  3. Di Bella, D., Lazzaro, F., Brusco, A., Plumari, M., Battaglia, G., Pastore, A., Finardi, A., Cagnoli, C., Tempia, F., Frontali, M., Veneziano, L., Sacco, T., and 14 others. Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28. Nature Genet. 42: 313-321, 2010. [PubMed: 20208537] [Full Text: https://doi.org/10.1038/ng.544]


Contributors:
Cassandra L. Kniffin - updated : 2/24/2011
Cassandra L. Kniffin - updated : 5/6/2010

Creation Date:
Cassandra L. Kniffin : 7/11/2006

Edit History:
alopez : 03/22/2024
carol : 08/14/2020
ckniffin : 08/10/2020
carol : 05/25/2016
carol : 1/20/2015
carol : 8/9/2013
wwang : 3/18/2011
ckniffin : 2/24/2011
terry : 12/22/2010
wwang : 5/18/2010
ckniffin : 5/6/2010
wwang : 7/14/2006
ckniffin : 7/11/2006